Merus N.V. (MRUS) Financial Statements (2025 and earlier)

Company Profile

Business Address YALELAAN 62
3584 CM UTRECHT, DE
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:537,027354,376326,700430,700207,800241,800
Cash and cash equivalent293,294204,246147,749241,435163,082197,612
Short-term investments243,733150,130142,480168,99044,67342,153
Other undisclosed cash, cash equivalents, and short-term investments   36,47120,275452,035
Receivables4,7103,9814,6986,6731,7492,911
Other current assets1,7171,5272,2042,1751,0581,913
Other undisclosed current assets25,6188,930(27,159)(15,369)7,386744
Total current assets:569,072368,814306,443424,179217,993247,368
Noncurrent Assets
Operating lease, right-of-use asset9,25411,36212,6183,7333,9075,215
Property, plant and equipment10,77012,13512,2223,5494,1153,715
Long-term investments and receivables187,00857,31236,45720,297 2,009
Long-term investments187,00857,31236,45720,297 2,009
Intangible assets, net (including goodwill)1,6791,8001,9502,3472,8432,876
Intangible assets, net (excluding goodwill) 1,6791,8001,9502,3472,8432,876
Other undisclosed intangible assets, net (including goodwill)      
Deferred income tax assets1,5201,1992,041417410 
Other noncurrent assets3,3902,8724,8112,0781,9491,905
Other undisclosed noncurrent assets      288
Total noncurrent assets:213,62186,68070,09932,42113,22416,008
TOTAL ASSETS:782,693455,494376,542456,600231,217263,376
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities48,12143,08445,42435,74325,13516,565
Taxes payable 206 
Accounts payable4,1644,6029,83413,2373,1263,029
Accrued liabilities43,95738,48235,59022,50621,80313,536
Deferred revenue29,93422,68529,41816,613625941
Debt      1,380
Due to related parties 18,04819,55417,901
Other undisclosed current liabilities9,0213,3204,0841,4941,432 
Total current liabilities:87,07669,08978,92671,89846,74636,787
Noncurrent Liabilities
Long-term debt and lease obligation:    2,2572,5213,872
Liabilities, other than long-term debt47,69030,06250,56166,24479,68791,417
Deferred revenue39,48219,57438,77110,962237780
Due to related parties 55,28279,45090,637
Operating lease, liability8,20810,48811,7902,2572,5213,872
Total noncurrent liabilities:47,69030,06250,56168,50182,20895,289
Total liabilities:134,76699,151129,487140,399128,954132,076
Equity
Equity, attributable to parent647,927356,343247,055316,201102,263131,300
Common stock6,9575,8834,7514,4813,2112,918
Additional paid in capital1,664,8221,126,054870,874787,869490,093441,395
Accumulated other comprehensive income (loss)(55,465)(22,533)(30,448)(9,221)9,0711,586
Accumulated deficit(968,387)(753,061)(598,122)(466,928)(400,112)(314,599)
Total equity:647,927356,343247,055316,201102,263131,300
TOTAL LIABILITIES AND EQUITY:782,693455,494376,542456,600231,217263,376

Income Statement (P&L) ($ in thousands)

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues36,13343,94741,58649,10729,94331,133
Gross profit:36,13343,94741,58649,10729,94331,133
Operating expenses(308,200)(200,494)(201,624)(139,083)(105,821)(89,790)
Operating loss:(272,067)(156,547)(160,038)(89,976)(75,878)(58,657)
Nonoperating income (expense)64,8924,80029,80323,399(9,132)3,700
Gain (loss), foreign currency transaction, before tax34,103(9,710)26,02224,663  
Other nonoperating income (expense)  1,059(1,135)(9,132)3,700
Loss from continuing operations before income taxes:(207,175)(151,747)(130,235)(66,577)(85,010)(54,957)
Income tax expense(8,151)(3,192)(959)(239)(503)(194)
Loss from continuing operations:(215,326)(154,939)(131,194)(66,816)(85,513)(55,151)
Loss before gain (loss) on sale of properties:(66,816)(85,513)(55,151)
Net loss available to common stockholders, diluted:(215,326)(154,939)(131,194)(66,816)(85,513)(55,151)

Comprehensive Income ($ in thousands)

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(215,326)(154,939)(131,194)(66,816)(85,513)(55,151)
Other undisclosed comprehensive income (loss)(32,932)7,915(21,227)(18,292)7,485(1,308)
Comprehensive loss, net of tax, attributable to parent:(248,258)(147,024)(152,421)(85,108)(78,028)(56,459)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: